2026 Scott M. Lippman: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	139	1728	1603	990	907	757	91133

Research.com Recognitions

Member of the Association of American Physicians
Member of the Association of American Physicians

Overview

Scott M. Lippman is affiliated with the University of California, San Diego in the United States. Their research primarily lies in the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a strong focus on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, and Genetics.

The scientist's main topics of study include:

Cancer Genomics and Diagnostics
Cancer Immunotherapy and Biomarkers
BRCA gene mutations in cancer
Lung Cancer Treatments and Mutations
Head and Neck Cancer Studies
Genetic factors in colorectal cancer
Pancreatic and Hepatic Oncology Research

Lippman has authored several notable papers, including:

"Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy," published in 2020 in Nature Communications
"Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial," published in 2021 in The Lancet Oncology
"Extrachromosomal DNA in the cancerous transformation of Barrett's oesophagus," published in 2023 in Nature
"Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test," published in 2022 in Communications Medicine
"JAK: Not Just Another Kinase," published in 2022 in Molecular Cancer Therapeutics

Frequent co-authors include:

Razelle Kurzrock
Shumei Kato
Ludmil B. Alexandrov
Andrew M. Lowy
Anirban Maitra

The scientist has published extensively in several venues, with multiple publications in:

Journal of Clinical Oncology
bioRxiv (Cold Spring Harbor Laboratory)
Cancer Medicine
Gastroenterology
Cancer Research

Scott M. Lippman has been recognized as a member of the Association of American Physicians. Their work contributes to advancing knowledge within the oncology and cancer research communities.

Best Publications

Comprehensive genomic characterization of head and neck squamous cell carcinomas

Michael S. Lawrence;Carrie Sougnez;Lee Lichtenstein;Kristian Cibulskis

4612
Citations
The Influence of Finasteride on the Development of Prostate Cancer

Ian M. Thompson;Phyllis J. Goodman;Catherine M. Tangen;M. Scott Lucia

3465
Citations
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

Ian M. Thompson;Donna K. Pauler;Phyllis J. Goodman;Catherine M. Tangen

3411
Citations
Molecular origins of cancer: Lung cancer

Roy S. Herbst;John V. Heymach;Scott M. Lippman;Scott M. Lippman

2771
Citations
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Scott M. Lippman;Eric A. Klein;Eric A. Klein;Phyllis J. Goodman;M. Scott Lucia

2665
Citations
Head and neck cancer.

Everett E. Vokes;Ralph R. Weichselbaum;Scott M. Lippman;Waun Ki Hong

2334
Citations
Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Eric A. Klein;Ian M. Thompson;Catherine M. Tangen;John J. Crowley

2130
Citations
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Victor G. Vogel;Joseph P. Costantino;D. Lawrence Wickerham;D. Lawrence Wickerham;Walter M. Cronin

2063
Citations
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial

Edward S. Kim;Vera Hirsh;Tony Mok;Mark A. Socinski

1743
Citations
Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

Waun ki Hong;Scott M. Lippman;Loretta M. Itri;Daniel D. Karp

1741
Citations
An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Lauren Averett Byers;Lixia Diao;Jing Wang;Pierre Saintigny

1270
Citations
Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy

Libero Santarpia;Scott M Lippman;Adel K El-Naggar

1116
Citations
The BATTLE Trial: Personalizing Therapy for Lung Cancer

Edward S. Kim;Roy S. Herbst;Ignacio Ivan Wistuba;Jiun-Kae Jack Lee

1023
Citations
Statins and cancer prevention

Marie-France Demierre;Peter D. R. Higgins;Stephen B. Gruber;Ernest Hawk

964
Citations
Type II Chemotherapy-Related Cardiac Dysfunction: Time to Recognize a New Entity

Michael S. Ewer;Scott M. Lippman

812
Citations
Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence.

Jacqueline Kerr;Cheryl Anderson;Scott M Lippman

705
Citations
Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)

Farshid Dayyani;Carol J. Etzel;Mei Liu;Chung Han Ho

643
Citations
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study

Jason K. Sicklick;Shumei Kato;Ryosuke Okamura;Maria Schwaederle

633
Citations
Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment

Li Mao;Jin S. Lee;You H. Fan;Jae Y. Ro

605
Citations
The Molecular Taxonomy of Primary Prostate Cancer

Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally

2
Citations

Frequent Co-Authors

Waun Ki Hong The University of Texas MD Anderson Cancer Center

J. Jack Lee The University of Texas MD Anderson Cancer Center

Reuben Lotan The University of Texas MD Anderson Cancer Center

Adel K. El-Naggar The University of Texas MD Anderson Cancer Center

Ian M. Thompson The University of Texas Health Science Center at San Antonio

Xifeng Wu Zhejiang University

Vassiliki A. Papadimitrakopoulou The University of Texas MD Anderson Cancer Center

Li Mao University of Maryland, Baltimore

Bonnie S. Glisson The University of Texas MD Anderson Cancer Center

Ignacio I. Wistuba The University of Texas MD Anderson Cancer Center

External Links

Wikipedia of Scott M. Lippman Personal website of Scott M. Lippman

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

The journey to a medical career is diverse, and many allied health roles support and enhance patient care outside of traditional MD paths. For those interested in nutrition, an online bachelor's in nutrition offers flexibility and foundational knowledge in dietetics, public health, and wellness.

Leadership roles in healthcare are also growing in demand. Earning a degree from top online mha programs that are cahme accredited can prepare you for management positions in hospitals and healthcare systems—often completely online.

For registered nurses, advancing your credentials is possible with an rn to bsn online no clinicals, offering schedule-friendly study and the ability to progress without on-site clinical requirements.

Aspiring nurse leaders and practitioners can further fast-track their careers with the fastest msn to dnp program, achieving a Doctor of Nursing Practice online in less time.

Exploring these pathways expands your options in healthcare, whether you’re seeking clinical, administrative, or public health roles.